References
Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G et al. International Scoring System for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.
Gondek LP, Tiu R, O’Keefe CL, Sekeres MA, Theil KS, Maciejewski JP . Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood 2008; 111: 1534–1542.
Mohamedali A, Gaken J, Twine NA, Ingram W, Westwood N, Lea NC et al. Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood 2007; 110: 3365–3373.
Heinrichs S, Kulkarni RV, Bueso-Ramos CE, Levine RL, Loh ML, Li C et al. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics. Leukemia 2009; 23: 1605–1613.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. International Agency for Research on Cancer (IARC): Lyon, 2008.
Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, McGuire C et al. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Blood 2009; 113: 6182–6192.
Bacher U, Haferlach T, Kern W, Weiss T, Schnittger S, Haferlach C . The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes. Cancer 2009; 115: 4524–4532.
Kelly LM, Gilliland DG . Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002; 3: 179–198.
Acknowledgements
We thank all co-workers in our laboratory for their excellent technical assistance as well as all physicians for referring patient material to our center.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S Schnittger, TH, WK and CH in part own the MLL Munich Leukemia Laboratory, which offers comprehensive leukemia diagnostics. JF, S Schindela, FD and AK are employed at MLL Munich Leukemia Laboratory and declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Flach, J., Dicker, F., Schnittger, S. et al. An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling. Leukemia 25, 713–718 (2011). https://doi.org/10.1038/leu.2010.304
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.304
- Springer Nature Limited
This article is cited by
-
Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia
Journal of Cancer Research and Clinical Oncology (2022)
-
Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance
Journal of Translational Medicine (2017)
-
Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients
Journal of Translational Medicine (2017)
-
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
Blood Cancer Journal (2017)
-
SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study
Journal of Experimental & Clinical Cancer Research (2014)